Abstract
Alterations of DNA methylation patterns have been suggested as biomarkers for diagnostics and therapy of cancers. Every novel discovery in the epigenetic landscape and every development of an improved approach for accurate analysis of the events may offer new opportunity for the management of patients. Using a novel high-throughput mass spectrometry on matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) silico-chips, we determined semiquantitative methylation changes of 22 candidate genes in breast cancer tissues. For the first time we analysed the methylation status of a total of 42 528 CpG dinucleotides on 22 genes in 96 different paraffin-embedded tissues (48 breast cancerous tissues and 48 paired normal tissues). A two-way hierarchical cluster analysis was used to classify methylation profiles. In this study, 10 hypermethylated genes (APC, BIN1, BMP6, BRCA1, CST6, ESRb, GSTP1, P16, P21 and TIMP3) were identified to distinguish between cancerous and normal tissues according to the extent of methylation. Individual assessment of the methylation status for each CpG dinucleotide indicated that cytosine hypermethylation in the cancerous tissue samples was mostly located near the consensus sequences of the transcription factor binding sites. These hypermethylated genes may serve as biomarkers for clinical molecular diagnosis and targeted treatments of patients with breast cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Eckhardt F, Lewin J, Cortese R, Rakyan VK, Attwood J, Burger M et al. (2006). DNA methylation profiling of human chromosomes 6 20 and 22. Nat Genet 38: 1378–1385.
Ehrich M, Nelson MR, Stanssens P, Zabeau M, Liloglou T, Xinarianos G et al. (2005). Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proc Natl Acad Sci USA 102: 15785–15790.
Ehrich M, Turner J, Gibbs P, Lipton L, Giovanneti M, Cantor C et al. (2008). Cytosine methylation profiling of cancer cell lines. Proc Natl Acad Sci USA 105: 4844–4849.
Issa JP . (2004). CpG island methylator phenotype in cancer. Nat Rev Cancer 4: 988–993.
Jones PA, Baylin SB . (2002). The fundamental role of epigenetic events in cancer. Nat Rev Genet 3: 415–428.
Kangaspeska S, Stride B, Metivier R, Polycarpou-Schwarz M, Ibberson D, Carmouche RP et al. (2008). Transient cyclical methylation of promoter DNA. Nature 452: 112–115.
Laird PW . (2003). The power and the promise of DNA methylation markers. Nat Rev Cancer 3: 253–266.
Li LC, Dahiya R . (2002). MethPrimer: designing primers for methylation PCRs. Bioinformatics 18: 1427–1431.
Lofton-Day C, Model F, Devos T, Tetzner R, Distler J, Schuster M et al. (2008). DNA methylation biomarkers for blood-based colorectal cancer screening. Clin Chem 54: 414–423.
Metivier R, Gallais R, Tiffoche C, Le Peron C, Jurkowska RZ, Carmouche RP et al. (2008). Cyclical DNA methylation of a transcriptionally active promoter. Nature 452: 45–50.
Nakayama H, Hibi K, Takase T, Yamazaki T, Kasai Y, Ito K et al. (2003). Molecular detection of p16 promoter methylation in the serum of recurrent colorectal cancer patients. Int J Cancer 105: 491–493.
Radpour R, Haghighi MM, Fan AX, Torbati PM, Hahn S, Holzgreve W et al. (2008). High-throughput hacking of the methylation patterns in breast cancer by in vitro transcription and thymidine-specific cleavage mass array on MALDI-TOF silico-chip. Mol Cancer Res 6: 1702–1709.
Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD et al. (2006). The consensus coding sequences of human breast and colorectal cancers. Science 314: 268–274.
Srinivasan M, Sedmak D, Jewell S . (2002). Effect of fixatives and tissue processing on the content and integrity of nucleic acids. Am J Pathol 161: 1961–1971.
Stanssens P, Zabeau M, Meersseman G, Remes G, Gansemans Y, Storm N et al. (2004). High-throughput MALDI-TOF discovery of genomic sequence polymorphisms. Genome Res 14: 126–133.
Suzuki MM, Bird A . (2008). DNA methylation landscapes: provocative insights from epigenomics. Nat Rev Genet 9: 465–476.
Trent JM, Touchman JW . (2007). Cancer. The gene topography of cancer. Science 318: 1079–1080.
Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, Leary RJ et al. (2007). The genomic landscapes of human breast and colorectal cancers. Science 318: 1108–1113.
Zhang YJ, Wu HC, Shen J, Ahsan H, Tsai WY, Yang HI et al. (2007). Predicting hepatocellular carcinoma by detection of aberrant promoter methylation in serum DNA. Clin Cancer Res 13: 2378–2384.
Zou HZ, Yu BM, Wang ZW, Sun JY, Cang H, Gao F et al. (2002). Detection of aberrant p16 methylation in the serum of colorectal cancer patients. Clin Cancer Res 8: 188–191.
Acknowledgements
We thank Professor Charles Cantor (SEQUENOM) for reading the manuscript and making critical comments, Vivian Kiefer for her excellent assistance and Regan Geissmann for proofreading the text. We are indebted to the patients for their cooperation. This work was supported in part by Swiss National Science Foundation (320000-119722/1) and Swiss Cancer League, Krebsliga Beider Basel and Dr Hans Altschueler Stiftung.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc)
Supplementary information
Rights and permissions
About this article
Cite this article
Radpour, R., Kohler, C., Haghighi, M. et al. Methylation profiles of 22 candidate genes in breast cancer using high-throughput MALDI-TOF mass array. Oncogene 28, 2969–2978 (2009). https://doi.org/10.1038/onc.2009.149
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2009.149
Keywords
This article is cited by
-
Comprehensive analysis of regulation of DNA methyltransferase isoforms in human breast tumors
Journal of Cancer Research and Clinical Oncology (2021)
-
Regulation of breast cancer metastasis signaling by miRNAs
Cancer and Metastasis Reviews (2020)
-
The combination of thymoquinone and paclitaxel shows anti-tumor activity through the interplay with apoptosis network in triple-negative breast cancer
Tumor Biology (2016)
-
Evaluation of wild yam (Dioscorea villosa) root extract as a potential epigenetic agent in breast cancer cells
In Vitro Cellular & Developmental Biology - Animal (2015)
-
Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer
Cancer Immunology, Immunotherapy (2014)